海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
- Postoperative Nausea and Vomiting;Postoperative Nausea and Vomiting;Postoperative Nausea and Vomiting;Postoperative Nausea and Vomiting
- Korea, Republic of
- 2015-06-17
Not Recruiting
- Clinical Trial Testing the efficacy and Safety of Two Ramucirumab Doses Given as Second Line Treatment to Patients with Stomach Cancer
- Second-Line Metastatic or Locally Advanced, Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma MedDRA version: 20.0 Level: PT Classification code 10063916 Term: Metastatic gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Canada, Czech Republic, Germany, Greece, Spain, Sweden, Turkey, Ukraine, United States
- 2015-06-09
Not Recruiting
- Analysis of toxic effects and efficacy of tyrosine kinase inhibitors as first line treatment in renal cell canrcinoma.
- Newly diagnosed patients of metastatic Renal Cell Carcinoma
- India
- 2015-05-21
Not recruiting
- Dysport in the Treatment of Glabellar Lines in Chinese Subjects
- Glabellar Lines;Glabellar Lines;Glabellar Lines;Glabellar Lines
- China
- 2015-05-19
Recruiting
- Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment
- Advanced Gastric Adenocarcinoma;Advanced Gastric Adenocarcinoma;Advanced Gastric Adenocarcinoma;Advanced Gastric Adenocarcinoma
- Korea, Republic of
- 2015-05-14
Not recruiting
- Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy
- Non Small Cell Lung Cancer;Non Small Cell Lung Cancer;Non Small Cell Lung Cancer
- Korea, Republic of
- 2015-05-12
Not recruiting
- PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy
- Breast Cancer;Brain Metastasis;Breast Cancer;Brain Metastasis;Breast Cancer;Brain Metastasis;Breast Cancer;Brain Metastasis
- China
- 2015-05-05
Not recruiting
- The Effectiveness of an On-line Training Program on Hospital Medical Staff to Improve Fire Knowledge
- Fire
- China
- 2015-04-27
Recruiting
- Irinotecan as 3rd Line Therapy in Gastric Cancer
- Stomach Neoplasms
- China
- 2015-04-23
Not Recruiting
- Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
- Kidney Transplantation # Chronic Kidney Failure;N18 - Chronic kidney disease
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, France, Germany, Hungary, India, Israel, Italy, Mexico, Poland, South Africa, Spain, Sweden, Switzerland, Turkey, United States
- 2015-04-14
Recruiting
- The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer
- Gastric Cancer
- China
- 2015-03-10
Recruiting
- Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
- Melanoma
- Korea, Republic of
- 2015-03-05
Authorised
- Clinical Trial Testing the Safety of Four Ramucirumab Doses Given as Second Line Treatment to Patients with Stomach Cancer
- Second Line Gastric or Gastroesophageal Junction Adenocarcinoma MedDRA version: 18.0 Level: PT Classification code 10063916 Term: Metastatic gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, France, Hungary, New Zealand, Poland, Romania, Russian Federation, Slovakia, United Kingdom, United States
- 2015-03-04
Recruiting
- Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients
- Colorectal Carcinoma
- China
- 2015-02-12
Not recruiting
- A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
- Recurrent Head and Neck Cancer;Metastatic Head and Neck Cancer
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2015-02-03
Recruiting
- Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment
- Non-small Cell Lung Cancer;Non-small Cell Lung Cancer;Non-small Cell Lung Cancer;Non-small Cell Lung Cancer
- Korea, Republic of
- 2015-02-01
Not recruiting
- Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®
- Glabellar Lines
- Australia, Brazil, Czech Republic, Kazakhstan, Lebanon, Russian Federation, Turkey, Ukraine
- 2015-01-29
Recruiting
- FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type
- Metastatic Colorectal Cancer
- China
- 2015-01-24
Not Recruiting
- Carbazitaxel in the second line treatment of gastric cancer
- Gastric adenocarcinoma failed one line of chemotherapy
- India
- 2015-01-23
Recruiting
- A Study to evaluate Safety and Efficacy of Endoxifen in Women with Metastatic Estrogen Receptor Positive Breast Cancer
- Metastatic Estrogen Receptor Positive Breast Cancer
- India
- 2015-01-23